AGP Executive Report
Last update: 2 hours agoBreast Cancer Access: NICE reversed its earlier “not cost-effective” call and will make Enhertu available on the NHS in England for about 1,000 women with HER2-low metastatic breast cancer, after a commercial deal—bringing relief for patients who said they’d been “died waiting.” Public Health & Misinformation: U.S. lawmakers pressed Trump’s health nominees on vaccines after measles deaths, while India’s health ministry warned states to act against unproven stem cell therapies. Medication Safety: A new focus on polypharmacy highlights why taking many medicines needs close monitoring as health changes, not automatic dismissal. Wellness in the Real World: Hyrox faced backlash after an athlete finished a race after a bowel accident, sparking urgent questions about health and safety rules. Food & Gut Trends: Lidl launched a hybrid “high-protein” meat range blending British meat and pea protein, and Biotiful expanded kefir with a Greek Recipe Kefir line aimed at gut-health shoppers. Fitness & Community: Peoria’s Active Adults program is using social connection and activity to support older adults’ physical and mental health. Traditional Medicine Watch: Herbal nail polish research points to turmeric/henna antifungal potential, while experts urge caution over online health advice.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
